DTIL - CIK 0001357874
The table below shows PRECISION BIOSCIENCES INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$65.84M | -$58.45M | -$84.11M | -$45.75M | -$10.85M | -$87.39M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$634.00K | -$215.00K | $5.83M | -$3.32M | -$5.80M | -$5.03M |
| Dividends paid | - | - | - | - | - |
PRECISION BIOSCIENCES INC reported operating cash flow of -$65.84M for fiscal year 2025. That is down 12.7% from -$58.45M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow declined from -$51.72M (FY 2018) to -$65.84M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $95.16M | $50.45M | $5.39M | $94.98M | $70.52M | $1.33M |